Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, has appointed Susan Keefe as Chief Financial Officer (CFO). Keefe has a 30-year tenure in finance, accounting and operations in the life sciences, most recently serving as the company’s acting CFO through her role at the company’s founder, Flagship Pioneering. “Susan brings a powerful combination of strategic insight, operational rigor and experience building and scaling public and private life s...